HOME >> BIOLOGY >> NEWS
Advances in Optics for Biotechnology, Medicine and Surgery

The primary goal of this conference is to bring together scientists, engineers, and clinicians interested in the application of optics to biotechnology, medicine, and surgery. In addition to formal presentations, this conference is intended to provide a forum for informal discussions and social interaction. In 2007 we aim to emphasize the medical applications of optics, with a focus on in vivo and molecular imaging, and to encourage participation by clinicians. The conference will be a continuation of meetings on this topic sponsored by Engineering Conferences International. This is the tenth conference in this series.

In each of the sessions, the invited speakers will define the current state of the art and suggest new and promising research directions. There will be extensive formal discussion periods in each session and informal discussions will be encouraged.

Sessions will include:

  • Intrinsic contrast microscopy;

  • Comprehensive, large field microscopy for basic research and clinical applications;

  • Molecular probes;

  • Intravital microscopy;

  • Imaging metabolic pathways;

  • Microendoscopy;

  • Tissue spectroscopy;

  • Molecular diffuse optical tomography and mesoscopic imaging;

  • Optical therapy and monitoring treatment response by optical methods;

  • Molecular imaging with scattered light;

Following the conference, invited speakers and poster presenters will be invited to submit their work to a special issue of the Journal of Biomedical Optics.


'"/>

Contact: Tressa Gaffaney
tgaffane@duke.poly.edu
718-260-3743
Engineering Conferences International
23-Jan-2007


Page: 1

Related biology news :

1. Advances in personalized medicine on agenda for 54th Society of Nucelar Medicine Annual Meeting
2. Advances in Forest Threat Assessment: Applications to Forest and Rangeland Management
3. Advances in the characterisation of the oyster mushroom genes
4. NIH gives $8M to University of Pittsburgh School of Medicine for myositis research
5. Journal of Nuclear Medicines impact grows, remains consistently high over past 5 years
6. University of Pittsburgh School of Medicine researchers develop off-the-shelf vascular grafts
7. Depiction of findings selected as 2007 Image of the Year by Society for Nuclear Medicine
8. 454 Life Sciences and Baylor College of Medicine complete sequencing of DNA pioneer
9. Nobel laureate James Watson receives personal genome in ceremony at Baylor College of Medicine
10. June 2007 issue of the Journal of Ultrasound in Medicine focuses on contrast-enhanced ultrasound
11. Journal of Nuclear Medicine releases new research faster

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Advances Optics for Biotechnology Medicine and Surgery

(Date:7/8/2015)... LAKES , N.J. and NEW YORK ... Company) and Guidepoint today announced BD ... start-up healthcare companies with free access to Guidepoint,s expert ... several start-ups that are developing cutting-edge technologies to improve ... a dedicated Guidepoint research manager, each start-up entrepreneur will ...
(Date:7/7/2015)... -- Research and Markets ( ... "Capacitive Fingerprint Sensors Patent Landscape" report ... fingerprint sensing technology is the most reliable and ... developed. This patent landscape focuses on fingerprint sensors ... of capacitive fingerprint sensors is closely linked to ...
(Date:7/2/2015)... , June 25, 2015 ... the addition of the "Natural Language Processing ... (Recognition, IVR, OCR, Pattern & Image Recognition) - ... offering. The key vendors occupying the ... IBM Corporation, Microsoft Corporation, NetBase Solutions, SAS Institute ...
Breaking Biology News(10 mins):BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2
(Date:7/30/2015)... ... July 30, 2015 , ... ... a field clinical study of its canine osteoarthritis stem cell product, currently under ... (Kansas City, KS) and will be marketed in the US by Aratana. This ...
(Date:7/30/2015)... 30, 2015   Senomyx , Inc. (NASDAQ: ... technologies to discover, develop, and commercialize novel flavor ingredients ... reported financial results for the second quarter 2015. ... we remain on track to achieve our commercial and ... Officer of the Company. "Since our last quarterly earnings ...
(Date:7/30/2015)... , July 30, 2015 Ascendis Pharma ... that applies its innovative TransCon technology to address ... results from a six-month Phase 2 study to ... Growth Hormone in 53 treatment-naïve, pre-pubertal children with ... are extremely pleased with the top-line results from ...
(Date:7/30/2015)... 2015  Discovery Laboratories, Inc. (Nasdaq: DSCO ... second $1.0M tranche under a previously awarded Phase ... at up to $3.0 million to support continued ... a potential medical countermeasure to mitigate acute and ... an initial $1.0 million under this grant in ...
Breaking Biology Technology:VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 2Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 3
Cached News: